J A Cairns

Summary

Affiliation: University of British Columbia
Country: Canada

Publications

  1. ncbi Prevention of stroke and systemic embolization in atrial fibrillation: a Canadian perspective
    John A Cairns
    University of British Columbia, Vancouver, British Columbia, Canada
    Pol Arch Med Wewn 122:428-36. 2012
  2. ncbi Canadian-led capacity-building in biostatistics and methodology in cardiovascular and diabetes trials: the CANNeCTIN Biostatistics and Methodological Innovation Working Group
    Lehana Thabane
    Department of Clinical Epidemiology and Biostatistics, McMaster University, 1200 Main Street West, Hamilton, Ontario, L8N 3Z5, Canada
    Trials 12:48. 2011
  3. ncbi The coxibs and traditional nonsteroidal anti-inflammatory drugs: a current perspective on cardiovascular risks
    J A Cairns
    University of British Columbia, Vancouver, Canada
    Can J Cardiol 23:125-31. 2007
  4. ncbi Monitoring the ACTIVE-W trial: some issues in monitoring a noninferiority trial
    John A Cairns
    University of British Columbia, Vancouver, British Columbia, Canada
    Am Heart J 155:33-41. 2008
  5. ncbi Canadian Network and Centre for Trials Internationally (CANNeCTIN): a national network for Canadian-led trials in cardiovascular diseases and diabetes mellitus
    John A Cairns
    University of British Columbia, Vancouver, British Columbia
    Can J Cardiol 26:353-8. 2010
  6. ncbi Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter
    John A Cairns
    University of British Columbia, Vancouver, British Columbia, Canada
    Can J Cardiol 27:74-90. 2011
  7. ncbi Long-term amiodarone therapy and the risk of complications after cardiac surgery: results from the Canadian Amiodarone Myocardial Infarction Arrhythmia Trial (CAMIAT)
    Eugene Crystal
    Department of Medicine, Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada
    J Thorac Cardiovasc Surg 125:633-7. 2003
  8. ncbi Clopidogrel resistance: more grist for the mill
    John A Cairns
    J Am Coll Cardiol 51:1935-7. 2008
  9. ncbi Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in preventive cardiology: which drug to use and what to expect in light of the ONTARGET trial
    John A Cairns
    Pol Arch Med Wewn 118:335-8. 2008

Collaborators

Detail Information

Publications9

  1. ncbi Prevention of stroke and systemic embolization in atrial fibrillation: a Canadian perspective
    John A Cairns
    University of British Columbia, Vancouver, British Columbia, Canada
    Pol Arch Med Wewn 122:428-36. 2012
    ..Recent clinical practice guidelines recommend these agents as alternatives to VKAs...
  2. ncbi Canadian-led capacity-building in biostatistics and methodology in cardiovascular and diabetes trials: the CANNeCTIN Biostatistics and Methodological Innovation Working Group
    Lehana Thabane
    Department of Clinical Epidemiology and Biostatistics, McMaster University, 1200 Main Street West, Hamilton, Ontario, L8N 3Z5, Canada
    Trials 12:48. 2011
    ..The ultimate goal is to enhance global health by contributing to efforts to reduce the burden of CVD and DM...
  3. ncbi The coxibs and traditional nonsteroidal anti-inflammatory drugs: a current perspective on cardiovascular risks
    J A Cairns
    University of British Columbia, Vancouver, Canada
    Can J Cardiol 23:125-31. 2007
    ..Current recommendations for the ongoing use of coxibs and the tNSAIDs are summarized...
  4. ncbi Monitoring the ACTIVE-W trial: some issues in monitoring a noninferiority trial
    John A Cairns
    University of British Columbia, Vancouver, British Columbia, Canada
    Am Heart J 155:33-41. 2008
    ....
  5. ncbi Canadian Network and Centre for Trials Internationally (CANNeCTIN): a national network for Canadian-led trials in cardiovascular diseases and diabetes mellitus
    John A Cairns
    University of British Columbia, Vancouver, British Columbia
    Can J Cardiol 26:353-8. 2010
    ....
  6. ncbi Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter
    John A Cairns
    University of British Columbia, Vancouver, British Columbia, Canada
    Can J Cardiol 27:74-90. 2011
    ..Alternatives to antithrombotic therapies are briefly discussed...
  7. ncbi Long-term amiodarone therapy and the risk of complications after cardiac surgery: results from the Canadian Amiodarone Myocardial Infarction Arrhythmia Trial (CAMIAT)
    Eugene Crystal
    Department of Medicine, Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada
    J Thorac Cardiovasc Surg 125:633-7. 2003
    ....
  8. ncbi Clopidogrel resistance: more grist for the mill
    John A Cairns
    J Am Coll Cardiol 51:1935-7. 2008
  9. ncbi Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in preventive cardiology: which drug to use and what to expect in light of the ONTARGET trial
    John A Cairns
    Pol Arch Med Wewn 118:335-8. 2008